Latest filing published 16 Jan 2025 for Fate Therapeutics INC. Read the official filing
No signal scores available.
This profile gathers the share dealings of Jerome Charles Bressi in Fate Therapeutics Inc. In total, 2 filings cover trades dated from 10 January 2025 to 15 January 2025.
No open-market purchase appears, only 1 sale worth €9,001. Other entries cover 1 share grant.
The newest entry dates from 16 January 2025: a share grant, in Fate Therapeutics Inc. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations